Pharm-Olam Enrolling UK Volunteers for Phase 3 Valneva COVID-19 Vaccine Study

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions is now enrolling volunteers in the United Kingdom into a pivotal Phase III COVID-19 vaccine study.